关注
Jennifer Hoy
标题
引用次数
引用次数
年份
CD4+ count–guided interruption of antiretroviral treatment
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
New England Journal of Medicine 355 (22), 2283-2296, 2006
26812006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
11762008
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel
MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ...
Jama 308 (4), 387-402, 2012
11442012
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA panel
HF Günthard, MS Saag, CA Benson, C Del Rio, JJ Eron, JE Gallant, ...
Jama 316 (2), 191-210, 2016
8572016
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel
MS Saag, CA Benson, RT Gandhi, JF Hoy, RJ Landovitz, MJ Mugavero, ...
Jama 320 (4), 379-396, 2018
7152018
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5792008
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy
JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ...
PLoS pathogens 10 (11), e1004473, 2014
5602014
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
BR Bavinton, AN Pinto, N Phanuphak, B Grinsztejn, GP Prestage, ...
The lancet HIV 5 (8), e438-e447, 2018
5382018
Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons
SM Crowe, JB Carlin, KI Stewart, CR Lucas, JF Hoy
JAIDS Journal of Acquired Immune Deficiency Syndromes 4 (8), 770-776, 1991
5001991
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel
MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ...
Jama 324 (16), 1651-1669, 2020
4722020
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
4512010
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial
A Carr, C Workman, DE Smith, J Hoy, J Hudson, N Doong, A Martin, ...
Jama 288 (2), 207-215, 2002
3952002
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel
HF Günthard, JA Aberg, JJ Eron, JF Hoy, A Telenti, CA Benson, ...
Jama 312 (4), 410-425, 2014
392*2014
Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection
MW Traeger, VJ Cornelisse, J Asselin, B Price, NJ Roth, J Willcox, BK Tee, ...
Jama 321 (14), 1380-1390, 2019
3772019
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study
A Martin, DE Smith, A Carr, C Ringland, J Amin, S Emery, J Hoy, ...
Aids 18 (7), 1029-1036, 2004
3772004
Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis
ACAP Leenders, P Reiss, P Portegies, K Clezy, WCJ Hop, J Hoy, ...
Aids 11 (12), 1463-1471, 1997
3471997
New spectrum of fungal infections in patients with cancer
E Anaissie, GP Bodey, H Kantarjian, J Ro, SE Vartivarian, R Hopfer, J Hoy, ...
Reviews of infectious diseases 11 (3), 369-378, 1989
3461989
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel
HF Gunthard, JA Aberg, JJ Eron, JF Hoy, A Telenti, CA Benson, ...
Jama 312 (4), 410-425, 2014
3062014
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society–USA panel
RT Gandhi, R Bedimo, JF Hoy, RJ Landovitz, DM Smith, EF Eaton, ...
Jama 329 (1), 63-84, 2023
2742023
Continuous antiretroviral therapy decreases bone mineral density
B Grund, G Peng, CL Gibert, JF Hoy, RL Isaksson, JC Shlay, E Martinez, ...
Aids 23 (12), 1519-1529, 2009
2672009
系统目前无法执行此操作,请稍后再试。
文章 1–20